Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY – Get Free Report)’s stock price traded down 0.9% during mid-day trading on Tuesday . The company traded as low as $32.16 and last traded at $32.29. 33,285 shares were traded during trading, a decline of 59% from the average session volume of 81,265 shares. The stock had previously closed […]
Oxycodone MarketThe global oxycodone market is on the brink of a significant upsurge, with Future Market Insight’s latest projections pointing towards an impressive valuation of US$ 8.92 billion by 2033. This forecast highlights a remarkable Compound Annual Growth Rate (CAGR) of 5.7%, showcasing substantial progress.
AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid tumours who have .
Varied regulatory approaches and vaccination strategies influence market trends, shaping demand and distribution patterns in diverse regions.Wilmington, Delaware, United States, Jan. 16, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The global influenza vaccine market is estimated to flourish at a CAGR of 7.2% from 2022 to 2031. Transparency Market Research projects that the overall sales revenue for influenza vaccine is estimated to reach US$ 7.2 billion by the end of 2031. The r
Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY – Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 19,700 shares, a growth of 258.2% from the December 15th total of 5,500 shares. Based on an average daily trading volume, of 130,400 shares, the […]